Dr_Microbe/iStock via Getty Images
Neurocrine Biosciences (NASDAQ:NBIX) is a pharmaceutical company that aims to improve the lives of people with medical needs and limited treatment options. Over the past 30 years, the company has utilized its expertise in neuroscience
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
This article aims to provide informational insight and not personal investment advice. The information presented is intended to be factual, but readers are encouraged to independently verify the information and consider their own financial situation, risk tolerance, portfolio diversification, etc. before making an investment decision. Some of the articles cover biotechnology companies with limited or no revenue, which makes the stocks speculative and prone to volatility. While the prospects may appear attractive, it's important to keep in mind that the future is unpredictable and there is a potential for significant losses.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
